Skip to main content
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: Arthritis Care Res (Hoboken). 2017 Nov 14;69(12):1780–1788. doi: 10.1002/acr.23201

Table 2.

Percent of individuals with positive responses to questions in the SLE-specific portion of the Connective Tissue Disease Screening Questionnaire (SLE-CSQ).

CSQ
Response
SLE, %
n=3357
ILE, %
n=432
HC, %
n=1525
SLE vs. ILE
OR (95%CI)P*
ILE vs. HC
OR (95%CI)P*
SLE vs. HC
OR (95%CI)P*
Cheek Rash 55.6 51.2 4.0 1.2 (1.0–1.5)
0.080
25.1 (18.2–34.5)
<0.0001
30.1 (23.0–39.2)
<0.0001
Discoid Lupus 2.0 2.3 0.0 0.8 (0.4–1.6)
0.627
NC
0.970
NC
0.971
Sun Sensitivity 61.9 58.6 7.1 1.2 (0.9–1.4)
0.176
18.4 (14.0–24.1)
<0.0001
21.1 (17.2–26.0)
<0.0001
Mouth Sores 52.1 50.0 6.2 1.1 (0.9–1.3)
0.411
15.1 (11.4–20.0)
<0.0001
16.4 (13.2–20.4)
<0.0001
Arthritis 78.8 78.2 19.0 1.0 (0.8–1.3)
0.793
15.4 (11.8–20.0)
<0.0001
15.9 (13.6–18.5)
<0.0001
Pleurisy 58.2 51.9 9.0 1.3 (1.0–1.6)
0.012
10.9 (8.4–14.1)
<0.0001
14.1 (11.7–17.0)
<0.0001
Protein in Urine 65.1 50.0 9.0 1.9 (1.5–2.3)
<0.0001
10.1 (7.8–13.1)
<0.0001
18.9 (15.6–22.8)
<0.0001
Seizure 19.4 14.4 2.8 1.4 (1.1–1.9)
0.012
5.9 (3.9–8.9)
<0.0001
8.5 (6.2–11.6)
<0.0001
Low Blood
Counts
76.6
66.0
23.5
1.7 (1.4–2.1)
<0.0001
6.3 (5.0–8.0)
<0.0001
10.7 (9.3–12.3)
<0.0001
Positive ANA 62.6 67.6 1.0 0.8 (0.6–1.0)
0.044
210 (122–363)
<0.0001
169 (101–282)
<0.0001
Cold Sensitivity 58.5 57.4 9.2 1.0 (0.8–1.3)
0.655
13.3 (10.3–17.3)
<0.0001
14.0 (11.6–16.8)
<0.0001
Rapid Hair
Loss
52.2
47.2
5.7
1.2 (1.0–1.5)
0.049
14.8 (11.1–19.7)
<0.0001
18.1 (14.4–22.7)
<0.0001
*

Bold P-values significant (P<0.05) by logistic regression.

HC: Healthy Controls.

NC: Not calculable due to 0 value.